NTE Events Archive
Events, By Category and Date:Subscribe - In Print
In Print» Full news listing
Monday, February 11, 2019
Françoise Baylis publishes an editorial arguing that we need public education, engagement and empowerment to reach ‘broad societal consensus’ on whether, not how, to pursue heritable genome editing.
Monday, July 2, 2018
Matthew Herder publishes a scholarly journal article on reviving the FDA's authority to publicly explain not only why new drug applications are approved but also why they've been rejected. (2 July 2018).
Tuesday, May 29, 2018
Françoise Baylis, Alana Cattapan and other experts from across Canada publish a fact sheet on the proposed changes to the AHR Act (29 May 2018).
Monday, April 16, 2018
Chris Kaposy publishes an Op-Ed in the New York Times (16 Apr 2018).
Tuesday, February 20, 2018
Françoise Baylis & Marcus MacLeod provide comments on the Tri‐Council Policy Statement: Proposed Revisions to TCPS 2 (2014) Research Involving Human Cells and Cell Lines.
Thursday, January 11, 2018
Françoise Baylis & Marcus McLeod publish a scholarly journal article critically questioning whether we are ready for first-in-human Phase 1 CRISPR gene editing cancer trials [Open Access].
Wednesday, November 15, 2017
Françoise Baylis and Lisa Ikemoto comment on CRISPR/Cas9, eugenics concerns, and whether the Council of Europe's ban on human germline genome editing should continue.